Alzheimer Disease: all 3,765 studies
Page 28 of 38. Open to participants first (881), then studies with results posted, then the rest; newest registration first within each.
- SOLFAMU Study of Nasal Brushing Collected OLFActory MUcosa Samples in the Diagnosis of Human EncephalopathiesStatus unknownNCT02951559Phase 4
- P75NTR, Diagnostic Biomarker for Alzheimer's Disease: Quantification Study in Cerebrospinal FluidCompletedNCT02946710
- Visuospatial Attention, Eye Movements and Instrumental Activities of Daily Living (IADLs) in Alzheimer's DiseaseCompletedNCT02941289Not applicable
- Aftobetin-HCl and Fluorescence Detection Measured by Sapphire II to Determine the Number and Timing of AdministrationsStatus unknownNCT02928211Phase 1
- Feasibility Trial of a Mediterranean Diet Pattern to Prevent Cognitive DeclineCompletedNCT02921672Not applicable
- Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research TrialsCompletedNCT02918539
- The Residential Care Transition ModuleCompletedNCT02915939Not applicable
- Risk Reduction for Alzheimer's DiseaseCompletedNCT02913664Phase 2/3
- A Medium Chain Triglyceride Intervention for Patients With Alzheimer DiseaseCompletedNCT02912936Not applicable
- Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Alzheimer's DiseaseWithdrawnNCT02912169Phase 1/2
- Investigating the Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) as a Treatment for Alzheimer's DiseaseCompletedNCT02908815Not applicable
- Clinical Trial of CT1812 in Mild to Moderate Alzheimer's DiseaseCompletedNCT02907567Phase 1/2
- Neurophysiological Correlates of Cognitive Tasks in Healthy Volunteers -WP3 P003TerminatedNCT02899403Not applicable
- Evaluation of the Safety and Potential Therapeutic Effects of CB-AC-02 in Patients With Alzheimer's DiseaseActive, not recruitingNCT02899091Phase 1/2
- Reference Database & Longitudinal Registry of the Normal and Pathological Aging BrainStatus unknownNCT02875496
- I2PETPG - Imidazoline2 Binding Sites in a Group of Participants Diagnosed With ADTerminatedNCT02874820Early Phase 1
- tDCS Effect on Cognitive Functions From Patients With Alzheimer's Disease or Progressive Primary AphasiaStatus unknownNCT02873546Not applicable
- Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior DisorderTerminatedNCT02871427Phase 2
- Identification of Epigenetic Markers Common to Obesity and Alzheimer's Disease in WomenStatus unknownNCT02868905Not applicable
- Use of Saliva for Alzheimer's Disease DiagnosisTerminatedNCT02864303Not applicable
- Predictive Value of Biomarkers of the Alzheimer's Disease (AD) in Elderly Patients With New-onset EpilepsyCompletedNCT02861846Not applicable
- COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICECompletedNCT02860338
- CPC-201 Alzheimer's Disease Type Dementia: PET StudyWithdrawnNCT02860065Phase 2
- A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy SubjectsCompletedNCT02859207Phase 1
- Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: Health OutcomeCompletedNCT02854917
- Alzheimer's Disease Neuroimaging Initiative 3CompletedNCT02854033
- Therapeutic Efficacy of Categorical Language Fluency Smartphone Game ApplicationCompletedNCT02848404Not applicable
- Memory for Action in Neurological PatientsTerminatedNCT02844855Not applicable
- Cognitive, Morphological and Neurobiological Progressive Aspects in Bipolar Disorders in the Elderly: Toward to a Neurodegenerescence Detection?Status unknownNCT02843906Not applicable
- Enteric Nervous System in Alzheimer DiseaseStatus unknownNCT02841605Not applicable
- A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female SubjectsCompletedNCT02840279Phase 1
- Development of a New Neuroimaging Method Aimed to Differentiate Mnesic Abilities of Alzheimer and Depressed PatientsStatus unknownNCT02840045Not applicable
- Neuro Imaging and Multimodal Alzheimer's DiseaseCompletedNCT02839187Not applicable
- Validation of a Scale of Well-Being Assessment (SIWA) in Patients With Alzheimer's Disease or a Related Disease.TerminatedNCT02838563
- Study of Degenerescence CSF Hallmarks in Older Bipolar PatientsStatus unknownNCT02836054Not applicable
- Pre-Clinical (Alzheimers) Diagnosis PCD = Optimum Outcomes OOStatus unknownNCT02835716
- Non-pharmacological Care of Alzheimer's Disease: Benefice of Musical InterventionsCompletedNCT02833870Not applicable
- Allogeneic Human Mesenchymal Stem Cells for Alzheimer's DiseaseStatus unknownNCT02833792Phase 2
- Cognitive-motor Intervention Using Virtual Reality for Middle-aged Individuals at High Dementia RiskStatus unknownNCT02832921Not applicable
- Evaluation of the Animal Intervention Used as TherapyStatus unknownNCT02829801Not applicable
- A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's DiseaseCompletedNCT02820896Phase 1
- Evaluation and Characterization of Behavioural Disorders and Dementias by the Behavioural Dysexecutive Syndrome Inventory (BDSI)CompletedNCT02819700
- MIND Diet Intervention and Cognitive DeclineCompletedNCT02817074Not applicable
- Role of Hypoxia Ans Sleep Fragmentation in Alzheimer's Disease. and Sleep Fragmentation.CompletedNCT02814045
- European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study (LCS)TerminatedNCT02804789
- Pharmaceutical Collaborative Care Integrated to a Multidisciplinary Psychosocial ProgramStatus unknownNCT02802371Not applicable
- Evaluation of [18F]RO6958948 as Tracer for Positron Emission Tomography (PET) Imaging of Tau Burden in Alzheimer's Disease ParticipantsCompletedNCT02792179Phase 1
- Patient-Centred Innovations for Persons With Multimorbidity - QuebecCompletedNCT02789800Not applicable
- Absolute Bioavailability of a Single, Fixed Subcutaneous Dose of Aducanumab in Healthy ParticipantsCompletedNCT02782975Phase 1
- Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) TrialTerminatedNCT02781220
- Implications for Management of PET Amyloid Classification TechnologyCompletedNCT02778971
- Study to Evaluate the Effect of a Vegetal Oil on Cognitive ImpairmentStatus unknownNCT02778581Not applicable
- A Validation Study of the Novel Application of Telehealth in Clinical Drug Development in Subjects With Mild Cognitive DeficitsCompletedNCT02778438
- Control and Intervention Programme on Alzheimer's Disease Risk FactorsCompletedNCT02772523Not applicable
- Neurostimulation and Cognitive Intervention in Alzheimer's DiseaseStatus unknownNCT02772185Phase 2/3
- Amyloid Beta-peptide 1-40 and Alzheimer's DiseaseCompletedNCT02770482Not applicable
- EEG/ERP Longitudinal Study in Alzheimer's Disease (AD)CompletedNCT02769234
- Biomarkers in Neural DisordersCompletedNCT02761707
- Relationship Between Down Syndrome (DS) and Alzheimer's Disease (AD)CompletedNCT02759887Not applicable
- The Study of Mechanism of Alzheimer's Disease Using Acupuncture Based on fMRIStatus unknownNCT02759159Not applicable
- An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's DiseaseCompletedNCT02756858Phase 2
- Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.CompletedNCT02750982Not applicable
- ABILITY - TelerehABILITation: TechnologY-enhanced Multi-domain at Home Continuum of Care ProgramCompletedNCT02746484Not applicable
- Patient-Centred Innovations for Persons With Multimorbidity - OntarioCompletedNCT02742597Not applicable
- Brain Sleep Deprivation MRI Effects (BEDTIME)WithdrawnNCT02741505Not applicable
- Behavioral Expressions in Alzheimer's DiseaseCompletedNCT02719834
- DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving DonepezilCompletedNCT02711683
- Relative Bioavailability Study in Healthy Subjects to Evaluate the Pharmacokinetics of HTL0009936 After One Dose of Prototype FormulationCompletedNCT02710188Phase 1
- Medium Chain Triglycerides and Brain Metabolism in Alzheimer's DiseaseCompletedNCT02709356Not applicable
- F 18 T807 Tau PET Imaging of Frontotemporal Dementia (FTD)WithdrawnNCT02707978Phase 2
- Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive DeteriorationCompletedNCT02707458Phase 1/2
- Randomized Trial of Low-dose Naproxen in Cognitively Intact Persons at Risk of Alzheimer's DementiaCompletedNCT02702817Phase 2
- Powerful Tools for Caregivers of Dementia PatientsCompletedNCT02697721Not applicable
- Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil).CompletedNCT02695004Phase 1
- Caregiver Burden and Depression: Caring for Those Who Care for OthersCompletedNCT02690896Not applicable
- Identification of Proteostasis-related Biomarkers in Alzheimer´s DementiaStatus unknownNCT02686554
- Biodistribution, Pharmacokinetics, and Safety of F-18 THK-5351 PET in Alzheimer's Disease Patients and Healthy Subjects.(Positron Emission Tomograph )CompletedNCT02686216Phase 1
- Effects of Light-therapy in Alzheimer's DiseaseCompletedNCT02686190Not applicable
- Early Counseling and Support for Alzheimer's Disease CaregiversStatus unknownNCT02685787Not applicable
- Multi-center Imaging Genetics Studies in ChinaStatus unknownNCT02681822
- Rehabilitation and Prophylaxis of Anomia in Primary Progressive AphasiaCompletedNCT02675270Not applicable
- Safety and Exploratory Efficacy Study of UCMSCs in Patients With Alzheimer's DiseaseStatus unknownNCT02672306Phase 1/2
- Support by Singing Sessions on Physical and Moral Pain : Assessment of Its Effectiveness in Alzheimer's DiseaseCompletedNCT02670993Not applicable
- Verification Study and Reactivity Study for the Validity of QuQu ScaleCompletedNCT02667665
- Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's DiseaseWithdrawnNCT02667496Phase 2
- The Trinity, Ulster and Department of Agriculture Cohort StudyStatus unknownNCT02664584
- Florbetaben as an Amyloid Plaque Marker in Elderly Patients With Focal or Disseminated Superficial HemosiderosisWithdrawnNCT02664571Not applicable
- Retinal Neuro-vascular Coupling in Patients With Neurodegenerative DiseaseStatus unknownNCT02663531Not applicable
- [18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative DiseaseCompletedNCT02656498Phase 2
- Comparison of Two Modes of Administration of the IADL Questionnaire, Assessing the Level of Functional Autonomy of Patients to Carry Out the Tasks of Daily Living: Randomized Controlled Trial Among Patients of a Memory ClinicCompletedNCT02654574Not applicable
- A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer PatientsStatus unknownNCT02648906Phase 4
- BPN14770 Single Ascending Dose Study in Healthy Male and Female SubjectsCompletedNCT02648672Phase 1
- Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy ParticipantsCompletedNCT02640092Phase 1
- HP Xenon-129 fMRI of Healthy Volunteers and Participants With Alzheimer's DiseaseTerminatedNCT02638519Early Phase 1
- Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive SymptomsCompletedNCT02626572Phase 2
- Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-ComtéTerminatedNCT02626377Not applicable
- EEG-cholinergic Index and Clinical Response to Treatment With Cholinesterase InhibitorsStatus unknownNCT02623764
- Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping StudyTerminatedNCT02612376
- Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's DiseaseCompletedNCT02600130Phase 1
- 24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's DiseaseCompletedNCT02579252Phase 2